戻る Agenda
Session 2
Speaker(s)
GVP Module XVI – Addendum III: Pregnancy Prevention Programme – Where We Are
Priya Bahri, PHD, RPH
European Medicines Agency, Netherlands
Senior Lead (Pharmacovigilance and Risk Management Guidance and Policy)
Treating Pregnant and Breastfeeding Women: The Reality of Clinical Practice as a GP and Pharmacist
Paul Ryan
PharmaBuddy.ie, GPConsult.ie, Dermabuddy.ie and GPConsult.co.uk, Ireland
GP and Pharmacist, Founder of PrescriptionRevision.com
Measuring the effectiveness of pregnancy prevention programme for valproate-challenges and lessons learned.
Liana Martirosyan
Medicines Evaluation Board (MEB), Netherlands
PRAC Member and PRAC Vice-Chair